Received Sep 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE) | SANOFI PASTEUR | 1 | UT8792LA | OT |
Pregnant patient received vaccine , with no reported adverse event; Initial information received on 28-Aug-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves Adult female patient who was exposed to vaccine influenza USP trival A-B SUBVIRION NO preservative vaccine [Fluzone] in context of pregnant patient received vaccine , with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported Pregnant patient received vaccine , with no reported adverse event occurred at 20 Weeks of pregnancy. The date of last menstrual period was reported as 11-Apr-2025. The estimated due date is 11-Jan-2026. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. On an unknown date, the pregnant patient received dose 1 of suspect influenza USP trival A-B SUBVIRION NO preservative vaccine Suspension for injection (Unknown strength) lot UT8792LA and expiry date Jun-2026 via intramuscular route in unknown administration site for Prophylactic vaccination (Immunisation) (exposure during pregnancy) (Latency same day) There were no information related to relevant prenatal testing after exposure. Action taken was not applicable. Additionally, at time of reporting, the pregnancy is still ongoing.